Secondary Cannabinoid Development

Secondary cannabinoid development refers to the biosynthetic pathways that produce minor cannabinoids—compounds like CBG, CBC, CBN, and CBDV—alongside the primary cannabinoids THC and CBD. These minor cannabinoids arise from the same precursor molecule (CBGA) but diverge through different enzymatic pathways controlled by specific synthase genes. Breeding programs increasingly track secondary cannabinoid expression as a distinct genetic trait, since ratios and absolute concentrations vary significantly across cultivars independent of THC or CBD levels. Understanding secondary cannabinoid genetics has become relevant for breeders pursuing novel chemotypes and for seed banks documenting cannabinoid diversity in landraces and modern crosses.

Breeders working in this category select for genotypes that upregulate minor cannabinoid synthases (CBGA→CBG, CBGA→CBC pathways, for example) to stabilize high-minor-cannabinoid phenotypes across generations. Marker-assisted selection and progeny testing are commonly used to isolate and maintain strains expressing elevated secondary cannabinoid profiles.